Tutti i video
SLA: a cosa serve anticipare la diagnosi
it
Prof. Antonio Chiò
Malattie neurodegenerative: quali prospettive
it
Prof. Antonio Chiò
Nuove terapie geniche per SLA e altre malattie neurodegenerative
it
Prof. Antonio Chiò
Identification of new genes responsible of ALS and FTD
it
Prof. Vincenzo Silani
ALS: tofersen, early access for patients with SOD1 mutation
it
Prof. Valeria Sansone
SLA: the EPOS trial of erythropoietin efficacy
it
Dott. Giuseppe Lauria
ALS management, valuable support from AI and Machine Learning
it
Prof. Vincenzo Silani
Farmaci epigenetici anti-neurodegenerativi: quale uso nella riabilitazione?
it
Prof. Marina Pizzi
ALS: liquid suspension of Riluzole to facilitate swallowing
it
Paolo Bettica
Studies on mitochondrial dysfunction and its clinical effects
it
Prof. Angela Messina
Is Erythropoietin effective in SLA: the results of a study
it
Dott. Giuseppe Lauria
Role of VDAC in the pathogenesis of neurodegenerative diseases
it
Prof. Angela Messina
The discovery of the peptide for the recovery of mitochondrial function
it
Prof. Angela Messina
Italfarmaco, between basic research and incremental innovation
it
Paolo Zambonardi
New peptide: studies on animal models and search for an industrial partner
it
Prof. Angela Messina